Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 1;75(1):14-29.
doi: 10.1093/jac/dkz348.

Impact of national interventions to promote responsible antibiotic use: a systematic review

Affiliations

Impact of national interventions to promote responsible antibiotic use: a systematic review

Jane Mingjie Lim et al. J Antimicrob Chemother. .

Abstract

Background: Global recognition of antimicrobial resistance (AMR) as an urgent public health problem has galvanized national and international efforts. Chief among these are interventions to curb the overuse and misuse of antibiotics. However, the impact of these initiatives is not fully understood, making it difficult to assess the expected effectiveness and sustainability of further policy interventions. We conducted a systematic review to summarize existing evidence for the impact of nationally enforced interventions to reduce inappropriate antibiotic use in humans.

Methods: We searched seven databases and examined reference lists of retrieved articles. To be included, articles had to evaluate the impact of national responsible use initiatives. We excluded studies that only described policy implementations.

Results: We identified 34 articles detailing interventions in 21 high- and upper-middle-income countries. Interventions addressing inappropriate antibiotic access included antibiotic committees, clinical guidelines and prescribing restrictions. There was consistent evidence that these were effective at reducing antibiotic consumption and prescription. Interventions targeting inappropriate antibiotic demand consisted of education campaigns for healthcare professionals and the general public. Evidence for this was mixed, with several studies showing no impact on overall antibiotic consumption.

Conclusions: National-level interventions to reduce inappropriate access to antibiotics can be effective. However, evidence is limited to high- and upper-middle-income countries, and more evidence is needed on the long-term sustained impact of interventions. There should also be a simultaneous push towards standardized outcome measures to enable comparisons of interventions in different settings.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Study flow diagram.
Figure 2.
Figure 2.
Countries where interventions to reduce inappropriate access to antibiotics were implemented and evaluated. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.
Figure 3.
Figure 3.
Countries where interventions to decrease inappropriate demand for antibiotics were implemented and evaluated. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.
Figure 4.
Figure 4.
Percentage change in DDD per 1000 inhabitants per day post intervention. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.
Figure 4.
Figure 4.
Continued.

Similar articles

Cited by

References

    1. Review on Antimicrobial Resistance. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations: Review on Antimicrobial Resistance 2016. https://amr-review.org/sites/default/files/160525_Final%20paper_with%20c....
    1. Klein EY, Van Boeckel TP, Martinez EM. et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA 2018; 115: E3463–70. - PMC - PubMed
    1. World Health Organization. Global Action Plan on Antimicrobial Resistance 2015. https://www.who.int/antimicrobial-resistance/global-action-plan/en/. - PubMed
    1. Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.. - PMC - PubMed
    1. Sterne JAC, Higgins JPT, Reeves BC; development group for ACROBAT-NRSI. A Cochrane Risk Of Bias Assessment Tool: for Non-Randomized Studies of Interventions (ACROBAT-NRSI), Version 1.0.0, 24 September 2014. http://www.bristol.ac.uk/population-health-sciences/centres/cresyda/barr....

Publication types

MeSH terms

Substances